Trial intelligence / Profile preview

Preemptive Pregabalin for Post-operative Pain in Myringoplasty

NCT03603626Withdrawn

Sponsor
Dhulikhel Hospital
Start
Sep 2015
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial in postoperative pain comparing Preemptive pregabalin with Placebo (2 arms). Primary endpoint: Post-operative pain severity assessed with VAS scale at 48 hours. Planned start Sep 2015; status: withdrawn.

02

Drugs

pregabalin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03603626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03603626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call